Sysmex
Sustainability Report

2016
Digest Version

Contents
1
3
5
7
8
9

Contents/Editorial Policy
Message from the Chairman and CEO
Sysmex at a Glance
Corporate Philosophy, Core Behaviors
Sysmex’s CSR Activities
Highlight 1

Accelerating the Advancement of Healthcare
by Gathering Knowledge and Technologies
from Both Inside and Outside the Company

11 Highlight 2Creating New Value through Global Human
Resource Development and Exchange

13 Global CSR Activity Highlights
13
14
15
16

Helping to Resolve Global Healthcare Issues
Japan
Americas/EMEA* * Europe, the Middle East and Africa
China/Asia Pacific

17 Corporate Information/

Information Available on the Website

1

Sysmex Sustainability Report 2016

Editorial Policy
Sysmex publishes the annual “Sysmex Sustainability Report” tocommunicate to stakeholders our approaches and activities
concerning corporate social responsibility (CSR), and to
facilitate dialogue with them. The digest version describes ourapproach to CSR, highlights key initiatives during the fiscal year
and introduces various topics by region. For more detailed
information in accordance with the core option of the Global
Reporting Initiative (GRI)’s Sustainability Reporting Guidelines,
Edition 4, see the “Sysmex Sustainability Report, Full Version(PDF)” and our CSR website. We also plan to publish the“Sysmex Report,” including both financial and non-financial
information, in 2016.

Inquiries about this report
CSR Promotion Department, Sysmex Corporation
1-5-1, Wakinohama-Kaigandori, Chuo-ku, Kobe, Hyogo, 651-0073, Japan
Tel +81-78-265-0500, Fax +81-78-265-0524

Organizations covered
Sysmex Group (Sysmex Corporation and its subsidiaries both in Japan andabroad). In this report, “Sysmex” refers to the Sysmex Group as a whole.
“Sysmex Corporation” refers to the Company on a stand-alone basis.

Period covered
Primarily fiscal 2015 (from April 1, 2015 to March 31, 2016). Some activities
conducted outside this period are also included.

Date of publication
Cautionary Statements
This report contains both forward-looking statements, plans and facts regarding thepast about Sysmex Corporation and its group companies (the Sysmex Group). These
forward-looking statements and plans are based on the current judgments andassumptions of the Sysmex Group in light of the information currently available toit. Uncertainties inherent in such judgments and assumptions, the future course of
our business operations, and future events may cause our actual results,
performance, or achievements to be materially different from any future results,
performance, or achievements either expressed or implied within suchforward-looking statements.

August 2016
Previous version: August 2015

Guidelines referenced• The Global Reporting Initiative (GRI)'s Sustainability Reporting
Guidelines, Edition 4• The Japanese Ministry of the Environment's Environmental Reporting
Guidelines (2012 ed.)Sysmex Sustainability Report 20162

Message from the Chairman and CEO

3

Sysmex Sustainability Report 2016

We aim to build trust and confidence among people
around the world. This has remained an important
goal since the time of our founding, as we work tocontribute to the development of healthcare andthe healthy lives of people.
Creating High-Value Testing and Diagnostic Technologies, and Contributing to
the Development of Healthcare
In line with our mission of “shaping the advancement of healthcare,” which is defined in the “Sysmex Way,”
the corporate philosophy of the Sysmex Group, Sysmex works to contribute to the development ofhealthcare and the healthy lives of people.
In recent years, advanced countries have been characterized by rapidly aging populations andincreasingly diverse healthcare needs, while emerging markets have been marked by population increases
and rapid developments in healthcare infrastructure. Meanwhile, in addition to being affected by the threeleading infectious diseases—HIV/AIDS, malaria and tuberculosis—developing countries have been facing
new types of infectious diseases, such as Ebola hemorrhagic fever. In this changing environment, testing is
expected to play an increasingly important role in disease prevention, early detection and determining
courses of treatment.
Since its founding, Sysmex has responded to increasingly sophisticated and diverse testing needs. We
currently provide products and after-sales support in the hematology and other in vitro diagnostics fields inmore than 190 countries around the world. Stepping up our R&D efforts toward the realization of
personalized medicine, we are pursuing collaborative research with research institutions, universities,
hospitals and other companies. We are working toward the creation of advanced, high-value testing anddiagnostic technologies, such as minimizing the physical burden on patients by using blood for the early
detection of cancer and the choice of treatment regimens best suited to individual patients. Furthermore, byleveraging the expertise and networks we have amassed, we have embarked on the collaborative
development of next-generation diagnostic drugs for dementia.
Going forward, we aim to respond swiftly to environmental changes and create new value that willcontribute to the advancement of healthcare. By so doing, we intend to address the shared desire of people
around the world to remain healthy.

Building Trust and Confidence Among Stakeholders
Sysmex holds dear the policy of building trust and confidence among stakeholders by fulfilling its corporate
philosophy and core behaviors. In addition to contributing to the development of healthcare, our core
behaviors indicate specifically how we are to build trust and confidence among our customers, employees,
business partners, shareholders and society, including resolving environmental issues, and we are pursuingbusiness activities in this vein.
Sysmex joined the United Nations Global Compact in February 2011. The mid-term CSR plan for fiscal
2015–2017, which we formulated in fiscal 2015, reflects the 10 principles of the Global Compact in the areasof human rights, labor, the environment and anti-corruption. In September 2015, the United Nations adopted
sustainable development goals. Taking these goals into account, going forward Sysmex will clarify the issues
it considers important and proactively redouble its CSR activities as a global company.
Sysmex will continue working toward the creation of a fulfilling and healthy society through its businessactivities, engaging proactively in environmental and social contribution activities, as it strives to meet the
expectations of its stakeholders by continuing to build trust and confidence among people around the world.
We would like to ask our stakeholders for their continued support and understanding of all our endeavors.

July 2016
Hisashi Ietsugu
Chairman and CEO

Sysmex Sustainability Report 20164

Sysmex at a GlanceContributing to a Healthy Society through Testing
Testing during hospital medical examinations and regular health checkups can be broadly divided into two types. One type, called “invivo diagnosis,” includes X-rays and other tests conducted directly on patients’ bodies. Another type, called “in vitro diagnosis” or IVD,
includes tests conducted on patient samples of blood, urine, cells and so on. Sysmex’s business is in the IVD field. We are a comprehensive
manufacturer in this field, conducting R&D, manufacturing, sales and after-sales support on the instruments, reagents and software
needed for IVD. Sysmex provides customers in more than 190 countries around the world with products and after-sales support. We
contribute to rapid diagnosis and the selection of treatment methods and help to reduce the burden on patients.

Sysmex’s Business Process

Sysmex Products

Creating High-Value Testing and
Diagnostic Technologies

Research andDevelopment

XN-Series: XN-2000
Automated Hematology Analyzer
Principal Diseases for Whichthe Instrument Is Used

Anemia, leukemia,
thrombocytopenia, etc.

UF-5000
Fully Automated Analyzer ofFormed Elements in Urine
Principal Diseases for Whichthe Instrument Is Used

Renal disease, urinary
tract disorders, etc.

Ensuring Product Quality and Providing
a Steady Supply of Products

Manufacturing

CS-5100
Automated Blood Coagulation Analyzer

HISCL-5000
Automated Immunoassay System

Principal Diseases for Whichthe Instrument Is Used

Principal Diseases for Whichthe Instrument Is Used

RD-100i
Gene Amplification Detector

ASTRIM FIT
Health Monitoring Analyzer

Thrombosis, thrombotic
disease (myocardial
infarction, cerebral
infarction), hemophilia, etc.

Infectious diseases(hepatitis, AIDS),
cancer, allergies, etc.

Providing Products and Services in Morethan 190 Countries around the World

Sales

What the Instrument
Helps to UnderstandWhat the Instrument
Helps to Understand

Lymph node metastasis ofbreast cancer, colon cancer
and stomach cancer

Oxygen transportcapacity of the blood

Specialized Reagents

pocH-100iV Diff
Automated Hematology Analyzer

Providing a Detailed Response to Inquiries

After-Sales
Support

Reagents for dilution,
staining and other aspectsof the Company’s products

What the Instrument
Helps to UnderstandThe state of health ofanimals (determining theneed for detailed tests)

5

Sysmex Sustainability Report 2016

Sysmex products are in use near you.

Hospitals
1 [Laboratories] Patient blood, urine and other samples
are examined using Sysmex’s products to discover reduced
function or abnormalities in physical organs and systems,
allowing for the early detection of disease, decisions on
treatment plans and monitoring the effects of treatment.

2 [Operating rooms] Sysmex’s products are used todetermine lymph node metastasis during breast cancer,
colon cancer and stomach cancer operations, helping tominimize the amount of surgery needed and, therefore,
the burden placed on the patient.

Animal Hospitals, Aquariums

Sports Training Facilities

3 Sysmex’s products are used to check the blood of dogs
and cats, as well as aquarium dolphins and zoo animals,
to manage health and determine whether more detailed
tests are necessary.

4 Sysmex’s products are used by professional sports
teams, high school, university and company track and fieldteams, and in sports gyms to measure athletes’ estimatedhemoglobin levels simply by inserting a finger and withoutsampling blood, thereby managing their physical condition.

2

4
1

3
1

4

3
4

Sysmex Sustainability Report 20166

Corporate Philosophy, Core Behaviors

Sysmex Group Corporate Philosophy

Core Behaviors
To our Customers
We deliver reassurance to our customers, through unmatched quality, advanced technologies, superior support, and actions
that consistently reflect the viewpoint of our customers.
We constantly look out for our customers’ true needs, and seek to generate new solutions to satisfy those needs.

To our Employees
We honor diversity, respect the individuality of each employee, and provide them with a workplace where they canrealize their full potential.
We value the spirit of independence and challenge, provide employees with opportunities for self-fulfillment andgrowth, and reward them for their accomplishments.

To our Business Partners
We deliver commitment to our client companies through broad-ranging partnerships.
We strive to be a company that can grow in step with our trade partners, through respect and mutual trust.

To our Shareholders
Our shareholders can rest assured that we will continue to improve the soundness and transparency of our management
policies, while promoting information disclosure and close communications.
We commit ourselves to a consistent yet innovative style of management, in order to achieve sustainable growth andincreased shareholder value.

To Society
We carry out our business in strict compliance with laws and regulations, as well as in adherence to high ethical standards.
As a responsible member of society, we play an active role in resolving environmental issues and other problems that
impact our society today.

7

Sysmex Sustainability Report 2016

Sysmex’s CSR Activities

Sysmex’s CSR Builds Trust and Confidence
through Practice of the Sysmex Way
Sysmex’s CSR builds trust and confidence among all its
stakeholders through the practice of the Sysmex Way, thecorporate philosophy of the Sysmex Group. The Sysmex Way
indicates the way the most basic corporate activities ought tobe conducted, consisting of three elements necessary forcontinued growth: Mission, Value and Mind. The mission
expresses the expansion of our business from activities centeredon the field of diagnostics—a focus since our establishment—tothe broader healthcare domain with its even closer connection
to human health. In this manner, the mission asserts our aim ofcontributing toward the realization of a society filled with
abundance, health and joy.
The Core Behaviors clarify provision of specific value tocustomers, employees, business partners, shareholders, society
and all our stakeholders. For example, to provide reassurance toall members of society we carry out our business in strict
compliance with laws and regulations, as well as in adherence tohigh ethical standards. We also consider it important to play anactive role in resolving environmental issues and other problems
that impact our society today.

External Evaluation
Incorporation in Sustainability and Other Indices

Dow Jones Sustainability
Asia Pacific Index
FTSE4Good Index
MSCI Global Sustainability Indexes
MSCI Global Socially Responsible Indexes
Ethibel Pioneer & Excellence
Ethibel Sustainability Index
Global 100(100 most sustainable companies in the world)

Participating in the UN Global Compact
To become more proactively
involved in CSR, in February 2011
Sysmex began participating in the
UN Global Compact, asserting its
endorsement of the compact’s 10
principles.

Formulating a Mid-Term CSR Plan Based on
Stakeholder Requirements and Expectations
In May 2015, Sysmex formulated a new mid-term CSR plan(fiscal 2015–2017)*, taking into account the globalization of ourbusiness and society’s diverse and sophisticated requirements
and expectations. The plan clarifies our material issues andsolutions considering the 10 principles of the UN Global
Compact, the ISO 26000 international standard on social
responsibility, and various requirements and expectations fromstakeholders.
We are currently working on determining the material
aspects incorporating significant issues for stakeholders andSysmex Group, to formulate the next mid-term CSR plan (fiscal
2017–2019).
In addition, we are undertaking initiatives to reduce theenvironmental impact of our business activities based on ourenvironmental action plan, the Sysmex Eco-Vision 2020.
* The mid-term CSR plan is included in the “Sysmex Sustainability Report,
Full Version (PDF)” and posted on our CSR site.
http://www.sysmex.co.jp/en/csr/sysmex_csr/plan.html

Sysmex Sustainability Report 2016

8

1

1

Highlight

2

4

9Sysmex Sustainability Report 2016

Accelerating the Advancement of Healthcare
by Gathering Knowledge and Technologies
from Both Inside and Outside the Company
3

Overview of the Sysmex Open Innovation Lab (SOLA)
Innovation Area:
This area is equipped with state-of-the-art,high-performance analytical instruments to researchand verify the seeds of new technologies. ( 1 2 )Sysmex Area:
This area, which is equipped with Sysmex’s
leading-edge diagnostic instruments, promotes therealization of products by fusing Sysmex’s existingknow-how with new technologies.
Communication Area:
This area fosters the generation of new concepts byencouraging interaction among researchers. ( 3 )ICT Area:This area provides supercomputer access toresearchers. ( 4 )Establishing an Open Innovation Lab witha View to Realizing Personalized Medicine
Drug efficacy and side effects differ, even among patients withthe same disease. Progress on gene and protein analysis
technologies in recent years have aided in uncovering disease
origins and mechanisms, and this in turn has raised expectations
for “personalized medicine.” This aims to boost treatment
efficacy and quality of life through the selection of treatment
methods tailored to individual patients.
To step up our R&D initiatives toward the realization of
personalized medicine, in October 2015 we opened the Sysmex
Open Innovation Lab (SOLA) and began collaborating withresearchers from outside the Company.
In one example, we are collaborating with JVC KENWOOD
Corporation to develop diagnostic instruments for themeasurement of exosomes. Exosomes are present in such bodily
fluids as blood, saliva and urine. It is expected that the many
substances they contain might be employed as biomarkers* fordiseases including cancer and central nervous system disorders.
Through this joint development, we are working toward thecreation of groundbreaking testing and diagnostic technologies
that could play a role in the early detection of cancer and themonitoring of treatment outcomes.
Aims of the Sysmex Open Innovation Lab (SOLA)
Universities

Medical institutions
Research institutions

Companies

Technology
Knowledge

Technology
Knowledge

Technology
Knowledge

We aim to generate new clinical value by fusing advanced
technologies to support leading-edge healthcare, such as
personalized medicine. To this end, we plan to set up a global
research unit comprising university researchers from Japan andaround the world, as well as making use of corporate working
groups.
* Substances that act as markers for certain diseases

Establishing a Joint Research Lab within
the National Cancer Center JapanIn September 2013, Sysmex entered into a comprehensive
collaboration agreement with the National Cancer Center
Japan to develop diagnostic reagents for cancer. To date wehave conducted joint research on seven topics.
In October 2015 we opened the Sysmex Cancer Innovation
Laboratory (SCI-Lab) within the National Cancer Center Japan
Hospital. This lab will further accelerate R&D in the field of cancer
diagnosis with the aim of realizing genomic medicine*1. This lab
meets ISO 15189*2 international standards for clinical laboratories.
The SCI-Lab employs next-generation sequencers to
conduct clinical research involving comprehensive genetic
testing to measure around 100 gene types related to various
types of cancer. This research is expected to contribute todecisions on appropriate treatment methods and use of drugs.
This lab is operated in alliance with RIKEN GENESIS Co., Ltd.,a Sysmex Group company with extensive experience in gene
analysis.
We will continue to collaborate closely with the National
Cancer Center Japan and RIKEN GENESIS, promoting research in theaim of realizing new cancer diagnosis methods as soon as possible.
*1 This type of medicine involves analyzing the relationship between genetic
information and disease in order to predict the onset risk of diseases and aid inselecting the most effective course of treatment.
*2 This international standard specifies requirements for quality and competence
in medical laboratories.

Sysmex technologies
Fusion of technologies

New clinical value

Mr. Koji Tsujita
Senior Adviser
Medical Systems
Development Taskforce
JVC KENWOOD
Corporation

Stakeholder Comment
SOLA’s Innovation Area provides an excellent
environment, with state-of-the-art analytical
instruments and efficiently arranged facilities.
The spacious Communication Area andconsideration for support staff allow extensive
research to be conducted effectively andcomfortably.
As well as the environment, I find the moststimulating and meaningful aspect of the lab tobe the way we can work with Sysmex
researchers, utilizing each other’s technologies
and knowledge for face-to-face deliberations
and joint experiments. For me, this is one of
SOLA’s main attractions.

Sysmex Cancer Innovation
Laboratory (SCI-Lab)

Mr. Atsushi Ochiai
Director
Exploratory Oncology
Research and Clinical
Trial Center,
National Cancer
Center Japan

Stakeholder Comment
The SCI-Lab has enabled the configuration andoperation of systems for providing actual medicalcare on cases within the center, including specimen
collection, genome testing, providing information
to patients and selecting treatment methods.
The genome diagnostics performed by the
SCI-Lab is at the forefront of new genomic
medicine in Japan, and should contribute
substantially to the structure of genomic
medicine in this country.
As the SCI-Lab develops, in addition to
genomic medicine I look forward to the introduction
and promotion of next-generation medical
technologies and diagnoses at actual clinics.

Sysmex Sustainability Report 201610

1Highlight

2Creating New Value throughGlobal Human Resource Development
and Exchange

2

3

5

6

4

Training underway at the Global Communication
CenterGlobal Exchange Program(This program aims to strengthen ties between
Japanese and overseas employees by fosteringinteraction and deepening mutual understanding.)(1 2 3 )New employee training ( 4 )Global Apprentice Program
Sysmex Partec ( 5 )Sysmex Shanghai ( 6 )11Sysmex Sustainability Report 2016

Promoting Human Resource Development
and Exchange Throughout the Group
Sysmex conducts its business on a global basis, and Group
employees number over 7,000, more than 50% of whom areoverseas (as of March 31, 2016).
To put into practice the Group corporate philosophy, theSysmex Way, and to instill trust and confidence in people
throughout the world, we recognize the need to enhance
individual employees’ skills and foster communication among
diverse human resources. We believe it is important to sharevalues and foster insights in order to create new value andencourage deeper cultural understanding.
To this end, in fiscal 2014 Sysmex formulated a global humanresource development system to facilitate human resource
development throughout the Group. Under this system, we arepromoting initiatives to enhance a sense of unity within theGroup, develop next-generation human resources, strengthen
networks within the Group, and foster cultural understanding.
The Global Apprentice Program that we introduced in fiscal
2011, targeting young employees, is one aspect of these initiatives.
Under this program, we solicit participation by employees who
have a clear awareness of issues and wish to be active in the
global environment. The program aims to cultivate future global
Key Outcomes of the Global Apprentice Program (Fiscal 2015)

Sysmex America
Developed an interface program for My Sysmex,
a comprehensive information tool for customers using
the Internet
Sysmex America/Sysmex Brazil
Provided support for the launch of South American
service locations
Sysmex Reagents America
Conducted surveys of local factory operations anddemand for the construction of next-generation factories
Sysmex Europe
Strengthened cooperation between the EMEA* region andSysmex Corporation for the global standardization of ICT
Jointly promoted business related to colon cancer in EMEA*
and Japan* Europe, the Middle East and Africa

Hajime Naruse
Manufacturing
Technology Department
Manufacturing
Management Division

human resources by providing employees with an opportunity toexperience working overseas early in their careers. Upon theirreturn, the employees participate in debriefing meetings. Thisapproach helps to convey information about local issues andconditions to Sysmex in Japan. A total of 38 people had taken
part in this program as of March 31, 2016.

Opening the Global Communication Center(GCC) as a New Place for Human Resource
Development and Exchange
In April 2015, we opened the Global Communication Center,equipped with accommodation facilities, as a new place toencourage human resource development and exchange.
The center is designed to encourage free and open discussion
among people whose cultures and values are diverse, and tofoster the expansion of personal networks. The center has a
discussion area with a flexible layout, and an open space where
people can sit in circles for discussions.
At the GCC, we conduct new employee training and training
for employees based on Sysmex’s human resource development
system, as well as cross-divisional study sessions and joint retreats
for global personnel. We also invite people from outside theCompany with a diverse range of values, so the center serves asa place for enhancing communication.
By cultivating and fostering interaction among the global humanresources of the future, Sysmex aims to encourage teamwork
and create new value that puts the Sysmex Way into practice.
Global Communication Center
Conversation

DialogueGoing
beyondorganizationalboundaries

Inspiring
diversity

Discussion

Open
and
flat

Sharing
Sysmex’s
DNA

Sharing of values, new insights

Quest for value, creation of value

Comments from an Employee Participant
in the Global Apprentice Program

Comments from an Employee Who Used
the GCC

I applied for the Global Apprentice Program
because I had past experience with a newfactory construction project, which I hoped tomake use of in the new expansion of our U.S.
factory. The experience I gained there helped
me to grow personally; it also strengthened my
network with local employees, which has mademy work easier since returning to Japan.

I underwent new employee training at the GCC.
The facility made it possible for people to gather
naturally, creating an atmosphere that encouraged
communication among the trainees. There wereping pong tables where we could enjoy a refreshingbreak when we weren’t in training. The scenerysurrounding the GCC was nice, and some trainees
took advantage of the location to go jogging in
the mornings.

Liyana Binti
Mohd Yazid
Business Development
Department
UB-Product Engineering
Division

Sysmex Sustainability Report 201612

Global CSR Activity Highlights

GlobalHelping to Resolve Global Healthcare Issues
Helping to Raise the Quality of Testing in Emerging Markets
and Developing Countries
Sysmex is working with governments and academic societies
in Asia’s emerging markets and developing countries toprovide external quality control*1, promote the standardizationof testing and help raise the quality of local healthcare. In
fiscal 2015, we signed a new agreement with Mongolia’s
Ministry of Health and Sports to support activities aimed atcreating external quality controls and a standard laboratory*2
to enhance the quality of testing of infectious diseases in
the immunochemistry testing field. We also signed anagreement with Cambodia’s Ministry of Health related toscientific support activities.
*1 A method under which the same specimens (such as artificially produced
blood) are distributed to multiple clinical laboratories, and the measurement
results obtained are analyzed using statistical methods, thereby allowing
the precision of individual laboratories’ measurement results to be evaluated.
The results are provided as feedback to these laboratories, helping to increase
the quality of testing.
*2 A model clinical laboratory for a region or country that serves a central
laboratory role.

In addition, Sysmex South Africa provides training on how
to operate laboratories in accordance with ISO 15189*3
international standard to help ensure the work quality oflaboratories in African countries. In fiscal 2015, the company
provided this support to a laboratory in Zimbabwe.
*3 An international standard that defines requirements for quality andcompetence by medical laboratories

Through external
quality control, we
have contributed tothe standardizationof testing in

6

countries

China, the Philippines, Mongolia, Thailand,
Cambodia and Myanmar (As of March 31, 2016)

Signing ceremony with the Mongolian Ministry of
Health and Sports

Hospital laboratory supported by Sysmex South
Africa (Zimbabwe)

Strengthening Our Lineup of Urinalysis Products

UD-10 fully automated imaging unit for formed elements in urine (left)
UF-5000 fully automated analyzer of formed elements in urine (center)
UC-3500 fully automated urine chemistry analyzer (right)

Throughout the world, demand for urinalysis is increasing, as this type of
testing provides a variety of physical information while placing a relatively small
physical and economic burden on patients. In September 2015, Sysmex
launched its UF-5000/4000/3000 fully automated analyzers of formed
elements in urine. These instruments offer enhanced performance and an
extended range of testing parameters, compared with conventional models.
Furthermore, in January 2016 we introduced the UD-10 fully automatedimaging unit for formed elements in urine. Through a business alliance withEIKEN CHEMICAL CO., LTD., we also began selling the UC-3500 fully
automated urine chemistry analyzer (in overseas markets), the first under ourown brand. These products, which employ the modular concept, can be
combined with other instruments to meet diverse urinalysis needs.

Helping to Resolve Healthcare Issues
in Developing Countries
To date, Sysmex has created testing technologies and developed
products for HIV, malaria and other diseases in an effort to help
diagnose infectious diseases in emerging markets and developing
countries. In fiscal 2015, Sysmex decided to participate in the
GHIT Fund, which states its vision as “one in which the crushingburden of infectious disease no longer prevents billions of people
in the developing world from seeking the level of prosperity andlongevity now common in the industrialized world,” becoming theonly manufacturer of diagnostic reagents to do so. Going forward,
we aim to continue working to address healthcare issues throughout
the world through our business activities.

13

Sysmex Sustainability Report 2016

GHIT Fund Framework
Targeted Diseases
HIV/
AIDS

Malaria

Tuberculosis

Neglected
tropicaldiseasesInstitutions
Receiving
Grant Funding
Grant Funding
for Joint R&D
in Japan and Overseas

JapanLowering Environmental Impact by Improving Logistics Processes
As Sysmex’s global business continues to expand, it is reviewing its logistics processes and systems as
distribution grows increasingly diverse and moving forward with packaging reforms. Such measures include
shifting the overseas shipment of products from air to sea transport, optimizing product package sizes,
conducting thorough loading simulations to increase container loading efficiency and working to reduce
CO2 emissions. In fiscal 2015, we shifted our mode of shipping immunochemistry reagents to China fromaircraft to ship, using reefer containers*. This move reduced CO2 emissions (per unit of sales) by 48%
compared with fiscal 2010 levels. We are also working to reduce waste, and we have introduced reusable
packaging that has decreased cardboard waste by 20 tons per year.
* A container with equipment to maintain its internal
temperature at a specified level

CO2 Emitted
through Logistics(Per unit of sales)
Down(t-CO2/billion yen)
0.80000.7252
Cardboard packaging

48%(Compared with fiscal 2010)

0.65090.60000.53480.41700.55580.40000.37940.20000

Reefer container

Reusable packaging

2010

2011

2012

2013

2014

2015

(Fiscal year)

Contributing to Healthcare by Funding
University Courses
Since fiscal 2004, Sysmex has contributed funds to a course of
assessment of clinical testing at the Kobe University Graduate Schoolof Medicine and promoted joint research on new clinical testing
technologies. This course is currently collaborating with Sysmex’s
Central Research Laboratories on the development of highly precise yet
simple diagnosis technologies for determining the risk of cardiovasculardisease by evaluating the function of high-density lipoproteins. We willcontinue researching laboratory medicine based on scientific evidence,
thereby continuing R&D initiatives aimed at the establishment of new
testing technologies and the commercialization of technologies. At
the same time, we will continue with our support for local universities
and other community contributions.

Activity report

Encourage Employee Volunteer
Activities

Cleanup activities

Results of the Social Contribution Point
Program in Fiscal 2015
Approximately 31% of Group employees in Japan
participated, a total of 1,042 people.
A total of ¥1,265,500 was donated, corresponding
to 12,655 points.

Study materials for children:
enough for 440 children

Nutrient powder: 62,250 packages
Polio vaccines: 34,560

Sysmex encourages employee volunteer activities
by a Social Contribution Point Program. Under
this program, employees can register points afterparticipating in volunteer efforts in private or social
contribution activities held by the Company. The
Company then makes contributions according to
the total number of points registered by employees
every year. In fiscal 2015, employees participatedin cleanup activities, donation of second-handbooks and other activities. As a result, the Company
donated about ¥1.26 million to children indeveloping countries, exceeding the ¥0.97 million
donated in fiscal 2014.

Sysmex Sustainability Report 201614

Global CSR Activity Highlights

Americas

Improving Customer Satisfaction by Launching an Educational Support Site
Sysmex America has striven over many years to provide
extensive support to its customers. Evincing its success,the company ranked top among manufacturers ofhematology analyzers in an IMV ServiceTrak survey(sponsored by IMV) of customer satisfaction for 16
consecutive years. In addition, in February 2016 Sysmex
launched a new educational support site for healthcare
professionals, providing recent clinical information to aid
in patient diagnosis and treatment.

Customer Satisfaction Survey Ranks
Sysmex America

No. 1

Educational support site for healthcare professionals:
Clinical Education for Cliniciansfor 16 Consecutive Years

Selected for the Companies That Care Honor Roll
Sysmex America was selected for the Companies That Care
Honor Roll 2016, sponsored by Companies That Care, a U.S.
nonprofit organization. Every year since 2009, Sysmex America
has been selected for this honor roll, which identifies companiesof excellence in a variety of areas, such as cultivating leaders,
employee compensation, extensive welfare, work–life balance,
a pleasant working environment and volunteer activities in
the region.

EMEA*

Expanding an Environmentally Conscious Reagent Factory
To meet growing demand in the EMEA region,in fiscal 2015 we expanded our reagent factoryin Germany, increasing production capacity to
1.5 times its former level. To reduce energy use
and CO2 emissions at the factory, we installed
solar panels and an ice thermal storage system*,a seasonal thermal storage climate control
system that makes use of natural energy.

* Europe, the Middle East
and Africa

Solar Power
Supplying
Approximately

15%of Total Needs* With this type of system, ice produced in the ground in winteris used in the summer for cooling. In winter, geothermal water,which is warmer than the ambient air, is used to supply heat.
Reagent factory in Germany

Promoting a Comfortable Working Environment
Sysmex Europe supports various employee working styles, suchas flextime and systems of shortened working hours. The company
also provides child-care allowances for working parents withchildren aged three or younger. It also concentrates on employee
health management by providing a training room and otherfacilities, and invites sports professionals and dieticians toprovide advice. The company is working to enhance its healthmanagement program.

Selected as a “Great Place to Work”
for three consecutive years

15

Sysmex Sustainability Report 2016

ChinaStriving to Boost Customer Satisfaction
Sysmex Shanghai conducted a customer satisfaction
survey in fiscal 2015. To gather comments from as manycustomers as possible, in addition to communicating
directly with customers the company conducted an online
survey, attracting opinions from some 1,500 customers.
The survey showed that customers gave Sysmex Shanghai
high marks in a number of categories, including after-sales
service, and that customers had additional expectations
and requests in such areas as periodic maintenance. Basedon the results of this survey, the company will work toincrease customer satisfaction levels further going forward.

Sysmex Shanghai call center

Gathering Customer Comments
through Direct Dialogue and on Line

Cooperating with Hospitals on Research into Early Detectionof Infectious Diseases

HISCL-5000 being used for joint research

Asia PacificSysmex’s HISCL-Series fully automated immunoassay system
is used broadly for diagnosing infectious and other diseases
and monitoring their courses of treatment, playing animportant role in the early detection and treatment of disease.
In fiscal 2015, Sysmex Shanghai began working with local
hospitals, using the HISCL-Series in joint research toward theearly detection of syphilis.

Providing Tools to Raise Awareness of Hemophilia*
In fiscal 2015, Sysmex Taiwan and Hemophilia Association of Taiwan
cooperated in producing a scientific handbook in traditional Chinese
related to hemophilia and materials that provided an easy-to-understandexplanation of recent trends on the treatment of hemophilia. The company
donated these materials to the association and distributed them at events.
The company also donated these materials to 10 hemophilia centersthroughout the country, where they are being used in awareness activities.
* A disorder occurring in people born with insufficiency of a protein that causes blood to clot

Enhancing Awareness Tools
in Response to Local Needs

Hemophilia handbook

Cooperating in Activities Aimed at Improving Hemophilia Treatment
Sysmex Asia Pacific is participating in the
Twinning Program* of the World Federation of
Hemophilia in the aim of improving hemophilia
treatment in emerging markets. In September
2015, the company participated in a workshop
held in Yangon, Myanmar, using Sysmex
instruments to provide training.

Workshop underway* This program aims to improve hemophilia care in emerging
markets by forming partnerships between hemophilia-relatedorganizations and healthcare facilities in advanced countries
and emerging markets, promoting the ongoing accumulationof knowledge.

Sysmex Sustainability Report 201616

Corporate Information

Corporate Overview(As of March 31, 2016)

Company name

Sysmex Corporation

EstablishedFebruary 20, 1968

Paid-in capital¥11,016 million

Representative

Hisashi Ietsugu, Chairman and CEO¥253.1

Net sales(¥ billion)
300.0
250.0

1-5-1, Wakinohama-Kaigandori, Chuo-ku,
Kobe 651-0073, Japan

Line of business

Development, manufacture, sales, and export/importof laboratory testing instruments, reagents, andrelated softwarebillion(¥ billion)
60.0
50.0

145.5

44.4
32.8

30.0

100.0

20.0

50.0

10.0

19.2

21.8

0

0

2011

2012

2013

2014

2015

2012

2013

2014

2015

(FY)

Number of employees(¥ billion)

¥36.2

50.0
40.0
30.0

billion

8,000
6,000

20.5

20.0

7,446

10,000

26.6

12.0

2011

(FY)

Net income

10.0

billion

40.0

184.5
134.7

¥56.9

Operating income

221.3

200.0
150.0

Head Office

5,314

5,594

2011

2012

6,211

6,739

4,000

14.1
2,000
0

0

2011

2012

2013

2014

2015

(FY)

2013

2014

2015

(FY)

Note: Including contract workers and part-time employees

Information Available
on the Website
Comprehensive Information Provided
on the CSR Site
Sysmex CSR

SearchMessage from the Chairman and CEO
Sysmex’s CSR Activities
CSR Management
Mid-Term CSR Plan
Results of Dialogue with Stakeholders
CSR Data
External Evaluation

Corporate GovernanceCompliance
Risk Management
2016 CSR Activity Highlights
Highlight 1 Accelerating the Advancement of

Healthcare by Gathering Knowledge
and Technologies from Both Inside andOutside the Company
Highlight 2 Creating New Value through Global
Human Resource Development andExchange

17

Sysmex Sustainability Report 2016

Involvement with Stakeholders
Involvement with Customers
Ensuring Quality and Safety
After-Sales Support/Scientific Activities
Stable Supply
Enhancing Customer Satisfaction and
Third-Party Evaluations
Contributing to Resolution of Healthcare Issues

Involvement with Shareholders
Involvement with Business Partners
Involvement with Employees
Respecting Human Rights
Employee Evaluation, Treatment,
and Human Resource Development
Promoting Diversity
Respecting Workers’ Rights
Considering Safety and HealthCorporate Citizenship Activities
Policy on Corporate Citizenship Activities
and Philanthropy
Activities to Promote a Healthy Society
Contributing to Local Communities
Promoting Employees’ Social Contribution
Activities

Net Sales by Destination/
Regional Subsidiaries and Affiliates

Japan

¥39.8

billion10 companies

Americas

EMEA**Europe,the Middle East
and Africa

China

¥59.8

billion9 companies¥68.2

billion27 companies¥65.1

billion4 companies

Asia Pacific¥20.1

billion13 companies

Employees by Region

3,339
1,029
2,006
492
580

Environmental Conservation Activities
Environmental Management Initiatives
Environment Friendliness in Product andService Life Cycles
Environmentally Conscious Operation
Other Environmental Conservation Activities
Green Procurement
Performance Data

Sysmex Sustainability Report
Guideline Comparative Table

Sysmex Sustainability Report 201618

1-5-1, Wakinohama-Kaigandori, Chuo-ku, Kobe 651-0073, Japan
Tel +81-78-265-0500 Fax +81-78-265-0524